title: Advances in the prevention, management, and treatment of community-acquired pneumonia.
abstract: Community-acquired pneumonia (CAP) is the infectious disease with the highest number of deaths worldwide. Nevertheless, its importance is often underestimated. Large cohorts of patients with CAP have been established worldwide and improved our knowledge about CAP by far. Therefore, current guidelines are much more evidence-based than ever before. This article discusses recent major studies and concepts on CAP such as the role of biomarkers, appropriate risk stratification to identify patients in need of hospitalisation or intensive care, appropriate empiric antibiotic therapy (including the impact of macrolide combination therapy and antibiotic stewardship), and CAP prevention with novel influenza and pneumococcal vaccines.
authors.affiliation: Center for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
authors.forename: Mathias W
authors.initials: MW
authors.lastname: Pletz
authors.affiliation: Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
authors.forename: Gernot G
authors.initials: GG
authors.lastname: Rohde
authors.affiliation: Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, Netherlands.
authors.forename: Tobias
authors.initials: T
authors.lastname: Welte
authors.affiliation: Division of Pulmonology, University Hospital Carl Gustav Carus, Dresden, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Kolditz
authors.affiliation: Department of Pulmonary Medicine, Inselspital, University Hospital, Bern, Switzerland.
authors.forename: Sebastian
authors.initials: S
authors.lastname: Ott
keywords: CAP; Streptococcus pneumoniae; community-acquired pneumonia; pulmonary infection